• Home
  • About Us
    • Company History
    • Our Scientific Approach
    • Other Approaches
    • Leadership
    • Board of Directors
    • Scientific Board
    • CLIA Laboratory
    • News
  • Products
    • Overview
    • MammoCheck
    • IGoCheck
    • Patient Information
    • Physician Information
    • Insurer Information
  • Pipeline Surveillance
    • Surveillance Overview
    • LuCheck
    • ProCheck
    • OvaCheck
  • Pipeline Early Detection
  • Research & Publications
  • Contact Us
  • Home
  • About Us
    • Company History
    • Our Scientific Approach
    • Other Approaches
    • Leadership
    • Board of Directors
    • Scientific Board
    • CLIA Laboratory
    • News
  • Products
    • Overview
    • MammoCheck
    • IGoCheck
    • Patient Information
    • Physician Information
    • Insurer Information
  • Pipeline Surveillance
    • Surveillance Overview
    • LuCheck
    • ProCheck
    • OvaCheck
  • Pipeline Early Detection
  • Research & Publications
  • Contact Us

Milagen, Inc.

Company History

Milagen spent over 25 years in research and development to find the best screening diagnostic option for the earlier detection of cancer and especially its recurrence. 


We developed and validated blood-based tests on thousands of patients for the earlier detection of the five major cancers that account for almost 50% of all cancer incidence (breast, colorectal, lung, prostate, and ovarian cancer). 


Our tests detect blood-secreted markers at the early development of cancer as well as its early recurrence. 


Our tests help patients and physicians to take preventive therapeutic measures and obtain better clinical outcomes.

Copyright © 2022 Milagen Inc. - All Rights Reserved.


Website Info | Privacy Policy


This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.


California Users: You can decline cookies by clicking "Decline" below.

DeclineAccept